Axonics (AXNX)
(Delayed Data from NSDQ)
$68.51 USD
-0.03 (-0.04%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $68.50 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AXNX 68.51 -0.03(-0.04%)
Will AXNX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXNX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXNX
Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates
Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates
AXNX: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy
Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System
Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates
Other News for AXNX
Hold Rating on Axonics Modulation Technologies Amidst Slowing Growth and Pending Acquisition
RBC Capital Remains a Hold on Axonics Modulation Technologies (AXNX)
Axonics: Q2 Earnings Snapshot
Axonics Reports Second Quarter 2024 Financial Results
Axonics Modulation Technologies GAAP EPS of $0.13, revenue of $114.6M